Related Experiment Videos
Ibuprofen levels in serum and synovial fluid
Scandinavian Journal of Rheumatology. Supplement
|January 1, 1981
Summary
This study tracked ibuprofen levels in children with juvenile chronic arthritis. Ibuprofen concentrations were lower and cleared faster in serum than in synovial fluid, indicating sustained presence in joints.
Area of Science:
- Pharmacokinetics
- Pediatric Rheumatology
- Drug Metabolism
Background:
- Juvenile chronic arthritis (JCA) is a significant pediatric rheumatologic condition.
- Effective pain and inflammation management in JCA often involves non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
- Understanding ibuprofen's pharmacokinetic profile in children with JCA is crucial for optimizing therapeutic outcomes.
Purpose of the Study:
- To investigate ibuprofen serum and synovial fluid levels in pediatric patients diagnosed with JCA.
- To determine the pharmacokinetic parameters of ibuprofen, including peak levels and half-life, in serum and synovial fluid.
- To compare ibuprofen distribution and elimination between serum and synovial fluid in this patient population.
Main Methods:
- Serum and synovial fluid samples were collected from 33 children (mean age 11 years) with JCA.
- Participants received a total daily dose of approximately 40 mg/kg of ibuprofen, divided into three administrations.
- Ibuprofen concentrations were quantified using appropriate analytical methods; pharmacokinetic parameters were calculated.
Main Results:
- Peak serum ibuprofen levels were observed 1-2 hours post-administration, with a mean elimination half-life of 2.3 ± 0.5 hours.
- Twelve hours after the last dose, mean serum ibuprofen levels were approximately 20 micromol/l.
- Synovial fluid exhibited less fluctuation in ibuprofen concentrations compared to serum, with mean peak levels of 65 micromol/l reached 5-6 hours post-intake and sustained higher levels at 12 hours.
Conclusions:
- Ibuprofen demonstrates a distinct pharmacokinetic profile in children with JCA, with slower elimination and higher sustained concentrations in synovial fluid compared to serum.
- These findings suggest that ibuprofen achieves and maintains therapeutic concentrations within the joint space, potentially contributing to its efficacy in managing JCA symptoms.
- Further research could explore the correlation between synovial fluid ibuprofen levels and clinical response in pediatric patients.